Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - CAPITAL EXPENDITURES
Capital Expenditures EBS - Emergent BioSolutions Inc.
-51.6 M
LAST VALUE
52.11%
2 YEAR CAGR
6.47%
5 YEAR CAGR
-2.07%
10 YEAR CAGR